BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16875495)

  • 1. Alterations of p53, BCL-2, and hMSH2 protein expression in the normal brain tissues, gliosis, and gliomas.
    Hussein MR; El-Ghorori RM; El-Rahman YG
    Int J Exp Pathol; 2006 Aug; 87(4):297-306. PubMed ID: 16875495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of p53, Bcl-2, and hMSH2 protein expression in the normal breast, benign proliferative breast disease, in situ and infiltrating ductal breast carcinomas in the upper Egypt.
    Hussein MR; Ismael HH
    Cancer Biol Ther; 2004 Oct; 3(10):983-8. PubMed ID: 15467428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human gliomas with wild-type p53 express bcl-2.
    Alderson LM; Castleberg RL; Harsh GR; Louis DN; Henson JW
    Cancer Res; 1995 Mar; 55(5):999-1001. PubMed ID: 7867012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocytochemical detection of p53 in human gliomas.
    Bruner JM; Saya H; Moser RP
    Mod Pathol; 1991 Sep; 4(5):671-4. PubMed ID: 1758878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of p53, Bcl-2, and hMSH2 protein expression in the cirrhotic, macroregenerative, dysplastic nodules and hepatocellular carcinomas in Upper Egypt.
    Hussein MR
    Liver Int; 2004 Dec; 24(6):552-60. PubMed ID: 15566504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexpression of genes involved in apoptosis in central nervous system neoplasms.
    Bruggers CS; Fults D; Perkins SL; Coffin CM; Carroll WL
    J Pediatr Hematol Oncol; 1999; 21(1):19-25. PubMed ID: 10029807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of immunohistochemistry in predicting behavior of astrocytic tumors.
    Ambroise MM; Khosla C; Ghosh M; Mallikarjuna VS; Annapurneswari S
    Asian Pac J Cancer Prev; 2010; 11(4):1079-84. PubMed ID: 21133628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of gemistocytes in astrocytoma progression.
    Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H
    Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of hMSH2 gene and mutant p53 in sporadic digestive tract tumors.
    Kang Y; Zhang Z; Wang J; Chen J; Peng B; Kang P
    Chin Med J (Engl); 2003 Jan; 116(1):53-6. PubMed ID: 12667388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship of bcl-2 gene expression with cell proliferation and apoptosis in human gliomas].
    Yu S; Pu P; Jiang D; An T; Guan X; Yang L
    Zhonghua Bing Li Xue Za Zhi; 2000 Feb; 29(1):12-5. PubMed ID: 11866884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 protein alterations in adult astrocytic tumors and oligodendrogliomas.
    Nayak A; Ralte AM; Sharma MC; Singh VP; Mahapatra AK; Mehta VS; Sarkar C
    Neurol India; 2004 Jun; 52(2):228-32. PubMed ID: 15269478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraffin section p53 protein immunohistochemistry in neuroectodermal tumors.
    Ng HK; Lo SY; Huang DP; Poon WS
    Pathology; 1994 Jan; 26(1):1-5. PubMed ID: 8165016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl-2 expression in higher-grade human glioma: a clinical and experimental study.
    Fels C; Schäfer C; Hüppe B; Bahn H; Heidecke V; Kramm CM; Lautenschläger C; Rainov NG
    J Neurooncol; 2000 Jul; 48(3):207-16. PubMed ID: 11100818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of mismatch repair enzymes, hMLH1 and hMSH2 is not associated with microsatellite instability and P53 protein accumulation in basal cell carcinoma.
    Saetta AA; Aroni K; Stamatelli A; Lazaris AC; Patsouris E
    Arch Dermatol Res; 2005 Sep; 297(3):99-107. PubMed ID: 16012876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDC25B, Ki-67, and p53 expressions in reactive gliosis and astrocytomas.
    Suren D; Isiksacan Ozen O
    J BUON; 2013; 18(4):1006-11. PubMed ID: 24344030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of 2 antiapoptotic factors in gliomas: bcl-2 overexpression and p53 mutations.
    Rodriguez-Pereira C; Suarez-Peñaranda JM; Barros F; Sobrido MJ; Vazquez-Salvado M; Forteza J
    Arch Pathol Lab Med; 2001 Feb; 125(2):218-23. PubMed ID: 11175638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in astrocytomas: relationship of p53, MDM-2, BCL-2 and PCNA immunohistochemical expression to tumor grade and overall patient survival.
    Ehrmann J; Kolár Z; Vojtĕsek B; Kala M; Komenda S; Oulton A
    Neoplasma; 1997; 44(5):299-304. PubMed ID: 9473789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis and cell proliferation: correlation with BCL-2 and P53 oncoprotein expression in human hepatocellular carcinoma.
    EI-Emshaty HM; Saad EA; Toson EA; Abdel Malak CA; Gadelhak NA
    Hepatogastroenterology; 2014; 61(133):1393-401. PubMed ID: 25436317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical analysis of Bcl-2, Bcl-X, Mcl-1, and Bax in tumors of central and peripheral nervous system origin.
    Krajewski S; Krajewska M; Ehrmann J; Sikorska M; Lach B; Chatten J; Reed JC
    Am J Pathol; 1997 Mar; 150(3):805-14. PubMed ID: 9060818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53, BCL-2 and BAX in non-small cell lung cancer brain metastases: a comparison of real-time RT-PCR, ELISA and immunohistochemical techniques.
    Stark AM; Hugo HH; Tscheslog H; Mehdorn HM
    Neurol Res; 2007 Jul; 29(5):435-40. PubMed ID: 17535549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.